At least four states are working to prevent pharmacies from compounding unauthorized solutions of Ozempic and Wegovy — two popular drugs from Novo Nordisk — because of safety concerns, NBC News reported May 3.
Read the full post on Becker's Hospital Review - Healthcare News
